Manulife (Manufacturers Life Insurance)
OTLK icon

Manulife (Manufacturers Life Insurance)’s Outlook Therapeutics OTLK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,268
Closed -$114K – 3004
2023
Q2 		$114K Buy
+3,268
New +$89.1K ﹤0.01% 2808
2022
Q2 		– Sell
-2,317
Closed -$82.5K – 3101
2022
Q1 		$82.5K Buy
+2,317
New +$72.3K ﹤0.01% 2986

Other funds holding OTLK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OTLK Position: Q3 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Outlook Therapeutics (OTLK) in Q3 2023, closing a stake of 3,268 shares — an estimated $114K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OTLK in Q1 2022 and held it in 2 quarters. The position peaked at $114K in Q2 2023. 81 funds tracked by Wall St. Rank hold OTLK as of Q3 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Outlook Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3,268 Outlook Therapeutics shares in Q3 2023, an estimated $114K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Outlook Therapeutics in Q1 2022 and held it in 2 quarters.
  • Manulife (Manufacturers Life Insurance)'s Outlook Therapeutics position peaked at $114K in Q2 2023.
  • 81 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2023, filed 15 Nov 2023.